According to an ovarian cancer study, GRK4α/β expression in nonmalignant granulosa cells is six times greater than that of malignant granular cells, while GRK4γ/δ expression is two times greater than that of nonmalignant tumor cells. The gene discussed is GRK4; the disease is neoplasm.